EUVIMEDEUVIMED entdecken
Crossref

Use of Autologous Umbilical Cord Blood in Neonatal Cardiac Surgery: A European Survey of Current Practices and Perceptions

Sonia Garcés-Sánchez, Álvaro Solaz-García, José Luis López-Guillén, Laura Torrejón-Rodríguez, Nerea Valles-Murcia, Alba Cayuela-Hernández iD, Alejandro Pinilla-Gonzalez iD, Pilar Argente Navarro, Vadym Tkachuk, Marta Aguar Carrascosa iD

Pediatric Blood & Cancer · 2026

DOI: 10.1002/mpo.70009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Sonia Garcés-Sánchez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesiology and Resuscitation Department, University and Polytechnics Hospital La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Cardiac Surgical Procedures, Fetal Blood, Blood Transfusion, Autologous, Practice Patterns, Physicians'. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate current clinical practices, identify perceived barriers, and explore healthcare professionals’ perspectives on the use of autologous umbilical cord blood (AUCB) in neonatal cardiac surgery across Europe.

Methods

A descriptive, cross‐sectional online survey was distributed to healthcare professionals involved in neonatal cardiac surgery. The questionnaire, developed ad hoc by a multidisciplinary expert team, assessed institutional AUCB use, perceived benefits and barriers, and professionals’ interest in further information. The survey was disseminated through European scientific societies and professional social media platforms. Data were collected anonymously and analyzed using descriptive statistics.

Results

A total of 50 responses were analyzed. The majority of respondents were neonatologists (50%), followed by pediatric cardiologists and pediatric anesthesiologists; 69% were based in Spain. Only 10% of participants reported institutional use of AUCB, primarily for selected patients in the postoperative setting. Reported benefits included reduced transfusion requirements and decreased exposure to allogeneic blood products. Among non‐users, key barriers included logistical challenges (32%), insufficient scientific evidence (27%), and preference for allogenic sources (10%). The most frequently cited overall obstacle for the general use of UCB was lack of education and training (75%), followed by regulatory restrictions. Only 18.8% considered the current evidence sufficient to support routine AUCB use. Despite limited implementation, overall interest was high (mean rating 4.6/5), with many respondents expressing interest in future collaboration.

Conclusions

AUCB use in neonatal cardiac surgery remains limited and institution‐dependent across Europe. Significant barriers—including insufficient training, logistical challenges, and perceived evidence gaps—hinder broader adoption. These findings highlight the need for standardized protocols, targeted educational strategies, and further clinical evidence to facilitate safe and effective integration of AUCB into neonatal cardiac care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Surgical ProceduresFetal BloodBlood Transfusion, AutologousPractice Patterns, Physicians'Cord Blood Stem Cell TransplantationHumansCross-Sectional StudiesInfant, NewbornEuropeSurveys and QuestionnairesFemaleMale

Stichwörter der Autor:innen

autologous umbilical cord bloodneonatal cardiac surgerysurvey

Autor:innen und Institutionen

  • Anesthesiology and Resuscitation Department, University and Polytechnics Hospital La Fe, Valencia, Spain.
  • Neonatal Research Unit, Health Research Institute La Fe, University and Polytechnics Hospital La Fe, Valencia, Spain.
  • Division of Cardiology, Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Division of Neonatology, University and Polytechnics Hospital La Fe, Valencia, Spain.
  • Neonatal ICU and Anesthesiology Department, Ukrainian Children's Cardiac Centre, Kyiv, Ukraine.

ORCID-Profile: Alba Cayuela-Hernández, Alejandro Pinilla-Gonzalez, Marta Aguar Carrascosa

Zitieren

APA

Garcés-Sánchez, S., Solaz-García, Á., López-Guillén, J. L., Torrejón-Rodríguez, L., Valles-Murcia, N., Cayuela-Hernández, A., Pinilla-Gonzalez, A., Navarro, P. A., Tkachuk, V., & Aguar Carrascosa, M. (2026). Use of Autologous Umbilical Cord Blood in Neonatal Cardiac Surgery: A European Survey of Current Practices and Perceptions. Pediatric Blood & Cancer. https://doi.org/10.1002/mpo.70009

Vancouver

Garcés-Sánchez S, Solaz-García Á, López-Guillén JL, Torrejón-Rodríguez L, Valles-Murcia N, Cayuela-Hernández A, et al. Use of Autologous Umbilical Cord Blood in Neonatal Cardiac Surgery: A European Survey of Current Practices and Perceptions. Pediatric Blood & Cancer. 2026. doi:10.1002/mpo.70009

BibTeX
@article{GarcsSnchez2026,
  author = {Garcés-Sánchez, Sonia and Solaz-García, Álvaro and López-Guillén, José Luis and Torrejón-Rodríguez, Laura and Valles-Murcia, Nerea and Cayuela-Hernández, Alba and Pinilla-Gonzalez, Alejandro and Navarro, Pilar Argente and Tkachuk, Vadym and Aguar Carrascosa, Marta},
  title = {Use of Autologous Umbilical Cord Blood in Neonatal Cardiac Surgery: A European Survey of Current Practices and Perceptions},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/mpo.70009}
}
Kostenlos starten →